TY  - CHAP
M1  - Book, Section
TI  - Treatment of Non–Small-Cell Lung Cancer: Radiation Therapy
A1  - Biswas, Tithi
A1  - Machtay, Mitchell
A2  - Grippi, Michael A.
A2  - Elias, Jack A.
A2  - Fishman, Jay A.
A2  - Kotloff, Robert M.
A2  - Pack, Allan I.
A2  - Senior, Robert M.
A2  - Siegel, Mark D.
PY  - 2015
T2  - Fishman's Pulmonary Diseases and Disorders, 5e
AB  - Lung  cancer  is  the  second  most  common  malignancy  in  the  United  States,  after  prostate  cancer  among  men  and  breast  cancer  among  women,  but  the  number  one  cause  of  cancer-related  mortality  in  both  genders.  Non–small-cell  lung  cancer  (NSCLC)  accounts  for  80%  to  85%  of  all  lung  cancers.1  Most  patients  with  NSCLC  receive  radiotherapy  as  part  of  their  treatment,  either  as  initial  management  or  later  in  the  course  of  their  disease.  This  may  include  thoracic  radiotherapy  and/or  irradiation  of  sites  of  metastatic  disease.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1122367617
ER  -